BoneKEy Reports | BoneKEy Watch
Potential allelic determinants of vitamin D deficiency
The genes associated with 25-hydroxycholecalciferol [25(OH) vitamin D] deficiency in regard to osteoporosis risk are proving elusive. Trummer et al. focused on three genes recently identified by genome-wide association studies, genotyping 342 patients within a cross-sectional study of bone mineral density and fracture risk and 1093 people from a prospective cohort study of patients in nursing homes.
The group-specific component (GC, which codes for a vitamin D binding protein) and cytochrome P450IIR-1 (CYP2R1, which codes for one of the cytochrome P450 proteins that is involved in vitamin D signaling) were not associated with BMD or the incidence of past fractures, although there was a significant association between GC genotypes and lower mean serum 25(OH) vitamin D levels in both groups of patients.
A variant in the gene DHCR7, which codes for 7-dehydrocholesterol reductase, an enzyme important in synthesizing vitamin D in the skin, did show a significant association with prospective fracture risk, with an odds ratio of 0.68 (95% CI 0.51–0.92; P=0.011).
Editor's comment: This work was performed on a modestly sized group of patients, but suggests that further study of GC, CYP2R1, and DHCR7 as potential predictive factors and perhaps even therapeutic targets in osteoporotic patients may be warranted.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.